APA (7th ed.) Citation

R, A., AM, F., HA, S., AB, I., HA, B., RT, M., . . . S, M. (2025). Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 208, 107061. https://doi.org/10.1016/j.ejps.2025.107061

Chicago Style (17th ed.) Citation

R, Albash, Fahmy AM, Shamsel-Din HA, Ibrahim AB, Bogari HA, Malatani RT, Abdelbari MA, and Mosallam S. "Intranasal Propranolol Hydrochloride-loaded PLGA-lipid Hybrid Nanoparticles for Brain Targeting: Optimization and Biodistribution Study by Radiobiological Evaluation." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 208 (2025): 107061. https://doi.org/10.1016/j.ejps.2025.107061.

MLA (9th ed.) Citation

R, Albash, et al. "Intranasal Propranolol Hydrochloride-loaded PLGA-lipid Hybrid Nanoparticles for Brain Targeting: Optimization and Biodistribution Study by Radiobiological Evaluation." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 208, 2025, p. 107061, https://doi.org/10.1016/j.ejps.2025.107061.